SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Fietkau R. Concurrent radiochemotherapy for the treatment of solid tumors. Strahlenther Onkol. 2012;188(suppl 3):263271.
  • 2
    Arends J, Bodoky G, Bozzetti F, et al. ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin Nutr. 2006;25:245259.
  • 3
    Barber MD, Ross JA, Fearon KC. The anti-cachectic effect of fatty acids. Proc Nutr Soc. 1998;57:571576.
  • 4
    Daly JM, Hoffman K, Lieberman M, et al. Nutritional support in the cancer patient. JPEN J Parenter Enteral Nutr. 1990;14(5 suppl):244S248S.
  • 5
    Huhmann MB, Cunningham RS. Importance of nutritional screening in treatment of cancer-related weight loss. Lancet Oncol. 2005;6:334343.
  • 6
    Tisdale MJ. Cancer cachexia: metabolic alterations and clinical manifestations. Nutrition. 1997;13:17.
  • 7
    Wallengren O, Lundholm K, Bosaeus I. Diet energy density and energy intake in palliative care cancer patients. Clin Nutr. 2005;24:266273.
  • 8
    Pai PC, Chuang CC, Tseng CK, et al. Impact of pretreatment body mass index on patients with head-and-neck cancer treated with radiation. Int J Radiat Oncol Biol Phys. 2012;83:e93e100.
  • 9
    Buntzel J, Krauss T, Buntzel H, et al. Nutritional parameters for patients with head and neck cancer. Anticancer Res. 2012;32:21192123.
  • 10
    Arends J, Zurcher G, Fietkau R. DGEM guidelines on enteral nutrition: oncology. Aktuel Ernaehr Med. 2003;28:S61S68.
  • 11
    Fietkau R. Principles of feeding cancer patients via enteral or parenteral nutrition during radiotherapy. Strahlenther Onkol. 1998;174(suppl 3):4751.
  • 12
    Finocchiaro C, Galletti R, Rovera G, et al. Percutaneous endoscopic gastrostomy: a long-term follow-up. Nutrition. 1997;13:520523.
  • 13
    Kondrup J. Can food intake in hospitals be improved? Clin Nutr. 2003;20(suppl 1):153160.
  • 14
    Senft M, Fietkau R, Iro H, Sailer D, Sauer R. The influence of supportive nutritional therapy via percutaneous endoscopically guided gastrostomy on the quality of life of cancer patients. Support Care Cancer. 1993;1:272275.
  • 15
    Pille S, Bohmer D. Options for artificial nutrition of cancer patients. Strahlenther Onkol. 1998;174(suppl 3):5255.
  • 16
    Hardman WE. (n-3) fatty acids and cancer therapy. J Nutr. 2004;134(12 suppl):3427S3430S.
  • 17
    van der Meij BS, Langius JA, Spreeuwenberg MD, et al. Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT. Eur J Clin Nutr. 2012;66:399404.
  • 18
    van der Meij BS, Langius JA, Smit EF, et al. Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment. J Nutr. 2010;140:17741780.
  • 19
    Declaration of Helsinki—Ethical Principles for Medical Research Involving Human Subjects, Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964 and amended by the 59th WMA General Assembly, Seoul, Korea, October 2008
  • 20
    ICH Topic E3, Note for Guidance on Structure and Content of Clinical Study Reports (CPMP/ICH/137/95), 1996.
  • 21
    Deurenberg P, Weststrate JA, Hautvast JG. Changes in fat-free mass during weight loss measured by bioelectrical impedance and by densitometry. Am J Clin Nutr. 1989;49:3336.
  • 22
    Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis—part I: review of principles and methods. Clin Nutr. 2004;23:12261243.
  • 23
    Pennock BE. Sensitivity of bioelectrical impedance to detect changes in human body composition. J Appl Physiol. 1990;68:22462247.
  • 24
    Kawaguchi T, Taniguchi E, Itou M, et al. Body cell mass is a useful parameter for assessing malnutrition and severity of disease in non-ascitic cirrhotic patients with hepatocellular carcinoma or esophageal varices. Int J Mol Med. 2008;22:589594.
  • 25
    Pirlich M, Schutz T, Spachos T, et al. Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites. Hepatology. 2000;32:12081215.
  • 26
    Kondrup J, Rasmussen HH, Hamberg O, Stanga Z. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr. 2003;22:321336.
  • 27
    Norman K, Schutz T, Kemps M, Josef Lubke H, Lochs H, Pirlich M. The Subjective Global Assessment reliably identifies malnutrition-related muscle dysfunction. Clin Nutr. 2005;24:143150.
  • 28
    Coates A, Porzsolt F, Osoba D. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer. 1997;33:10251030.
  • 29
    Dancey J, Zee B, Osoba D, et al. Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group. Qual Life Res. 1997;6:151158.
  • 30
    Bohannon RW. Dynamometer measurements of hand-grip strength predict multiple outcomes. Percept Mot Skills. 2001;93:323328.
  • 31
    Bauer P, Köhne K. Evaluation of experiments with adaptive interim analyses. Biometrics. 1994;50:10291041.
  • 32
    European Agency for the Evaluation of Medicinal Products (EMEA). CH Topic E9, Statistical Principles for Clinical Trials. Step 4, Consensus guideline. CPMP/ICH/363/96. 1998. 1999.
  • 33
    Colomer R, Moreno-Nogueira JM, Garcia-Luna PP, et al. N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr. 2007;97:823831.
  • 34
    Dewey A, Baughan C, Dean T, Higgins B, Johnson I. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Syst Rev. 2007:CD004597.
  • 35
    Mazzotta P, Jeney CM. Anorexia-cachexia syndrome: a systematic review of the role of dietary polyunsaturated fatty acids in the management of symptoms, survival, and quality of life. J Pain Symptom Manage 2009;37:106977.
  • 36
    Ries A, Trottenberg P, Elsner F, et al. A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: an EPCRC cachexia guidelines project. Palliat Med. 2012;26:294304.
  • 37
    Murphy RA, Mourtzakis M, Chu QS, Baracos VE, Reiman T, Mazurak VC. Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy. Cancer. 2011;117:17751782.
  • 38
    van der Meij BS, de Graaf P, Wierdsma NJ, et al. Nutritional support in patients with GVHD of the digestive tract: state of the art. Bone Marrow Transplant. 2013;48:474482.
  • 39
    Ravasco P, Monteiro-Grillo I, Marques Vidal P, Camilo ME. Nutritional risks and colorectal cancer in a Portuguese population. Nutr Hosp. 2005;20:165172.
  • 40
    Russell DM, Shike M, Marliss EB, et al. Effects of total parenteral nutrition and chemotherapy on the metabolic derangements in small cell lung cancer. Cancer Res. 1984;44:17061711.
  • 41
    Wigmore SJ, Barber MD, Ross JA, Tisdale MJ, Fearon KC. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer. 2000;36:177184.